Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
eRapa for Bladder Cancer Prevention
NCT04375813Phase 2Active, not recruiting
- Start
- Jan 2021
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in non-muscle-invasive bladder cancer (NMIBC). Started Jan 2021; status: active, not recruiting.
02
Drugs
sirolimus
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT04375813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04375813.